Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
29 Sep 2016 FDA Modifies the Dosage Regimen for Currently Approved Indications for Nivolumab Genitourinary cancers - Melanoma and other skin tumours - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
05 Sep 2016 Completion of Rolling Submission of New Drug Application for Brigatinib to the US FDA Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Aug 2016 Latest NICE Medtech Innovation Briefings and Technology Appraisal Guidance Recommendations for Cancer Breast cancer - Genitourinary cancers - Haematologic malignancies - Lung and other thoracic tumours - Gastrointestinal cancers
25 Jul 2016 EMA Recommends Extension of Therapeutic Indications for Crizotinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
30 Jun 2016 NICE Issues Technology Appraisal Guidance for Ceritinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
28 Jun 2016 EMA Recommends To Extend Indications for Pembrolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
03 Jun 2016 FDA Approves First Blood Test to Detect EGFR mutations associated with NSCLC Personalised medicine - Lung and other thoracic tumours
30 May 2016 Withdrawal of the EU Marketing Authorisation Application for Rociletinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
23 May 2016 Unprecedented Progress in the Treatment of NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
02 May 2016 EMA Adopts a New Indication for Bevacizumab Lung and other thoracic tumours - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Osimertinib Combined With Durvalumab in EGFR-mutant Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Updates from CheckMate 063 and 017 Trials Confirm Nivolumab Efficacy in Patients with Advanced Platinum-Refractory Squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
15 Apr 2016 ELCC 2016 News: Novel Durvalumab plus Gefitinitib Shows Promise in EGFR Mutated NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Comprehensive Molecular Profiling Shows Disparity Between Primary NSCLC Tumours and Metastases Pathology/Molecular biology - Lung and other thoracic tumours
15 Apr 2016 ELCC 2016 Press Release: Studies Confirm Benefit of Plasma Genotyping to Predict Treatment Benefit in Patients with Non-Small-Cell Lung Cancer Lung and other thoracic tumours